News
AstraZeneca and the Memorial Sloan Kettering Cancer Center (MSK) have tapped digital health tech company IgniteData to provide an automated data capture tool for a phase 3 clinical trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback